✦ LIBER ✦

A Rationale for the Reinitiation of Adjuvant Tamoxifen Therapy in Women Receiving Fewer than 5 Years of Therapy

✍ Scribed by William J. Gradishar; Richard Hellmund

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genotypic and allelic frequencies of SUL

✍ J.L. Grabinski; L.S. Smith; G.B. Chisholm; R. Drengler; G.I. Rodriguez; A.S. Lan 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 142 KB

75 - The effect of adjuvant tamoxifen th

✍ J. Zidan; W. Robenstein; A. Amira; R. Jobani 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Strategies for the Prevention of Treatme

✍ Hope S. Rugo 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 131 KB

Genetic polymorphisms ofCYP2D6increase t

✍ Damodaran, Solai Elango; Pradhan, Suresh Chandra; Umamaheswaran, Gurusamy; Kadam 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 266 KB

PCN116 A SURVIVAL BASED COST-EFFECTIVENE

✍ K El Ouagari; S Kaura; JD Karnon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Cost-effectiveness analysis of 5 years o

✍ Jae Jeong Yang; Sue K. Park; Lisa Y. Cho; Wonshik Han; Boyoung Park; Hyeongsu Ki 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 153 KB